US : Mirum Pharmaceuticals, Inc. - MIRM | 1Q21 Update: Expansion into China and Possible Foray into Gene Therapy

Most Viewed See latest

This publication is being distributed by Tellimer solely for information purposes irrespective of a particular user's means, financial situation or investment objectives. The information does not con...

Full Tellimer disclaimers